Posted on April 24, 2009 by cartier@bio
Josh Green, general partner at MDV-Mohr Davidow Ventures and three entrepreneurs visited Capitol Hill on Wednesday to testify before the House Small Business Committee about the need to reauthorize the SBIR program.
The Wall Street Journal’s Venture Capital Dispatch blog reported,
“Companies receiving venture funding may have other innovation in the pipeline worth [...]
Filed under: Congress, In the News, SBIR, Uncategorized | Tagged: Congress, House Small Business Committee, SBIR, venture capital | 1 Comment »
Posted on April 6, 2009 by cartier@bio
A new regional investor angel fund has sprouted up in the New England area — Mass Medical Angels (MA2) is devoting all of its funds to backing life science startups. The group says its focus is on early stage life science companies looking to raise $250K to $3.0M.
According to the group’s website
Depending on the amount [...]
Filed under: SBIR, venture capital | Tagged: biotech, venture capital | Leave a Comment »
Posted on April 2, 2009 by cartier@bio
The economic news this week wasn’t all doom and gloom – Google announced Google Ventures, a new venture capital fund that will finance biotechnology start ups, among other things.
According to Google Blog:
At its core, Google Ventures is charged with finding and helping to develop exceptional start-ups. We’ll be focusing on early stage investments across [...]
Filed under: BIO, In the News, venture capital | Tagged: biotechnology, Google, Innovation, start-up, VC, venture capital | Leave a Comment »
Posted on July 16, 2008 by cartier@bio
The feature story in the July 2008 Oncology Business Review is “On-Conversation with Michael Weingarten, Director, Small Business Innovation Research program (SBIR), Office of the Director, National Cancer Institute.”
NOTE: We have highlighted a few of Weingarten’s answers below. Please follow the links for the full interview.
OBR: HOW HAS THIS PROGRAM BEEN ADMINISTERED TO THIS [...]
Filed under: Finding Cures, SBIR, venture capital | Tagged: Cancer, Michael Weingarten, NIH, Phase I, SBIR, venture capital | Leave a Comment »
Posted on July 9, 2008 by cartier@bio
With three weeks remaining before the August recess, time is running short for the Senate to continue to meet regarding the SBIR bill. (NOTE: the House passed a SBIR reauthorization bill in April). Yesterday the Wall Street Journal ran a piece outlining the debate on who should receive these SBIR grants: Should a small business [...]
Filed under: Congress, In the News, SBIR, venture capital | Tagged: House, SBIR, Senate, VC, venture capital, Wall Street Journal | Leave a Comment »
Posted on June 16, 2008 by cartier@bio
A post on SBIRGA asked the question, “Just how short-sighted is the VC community?” The post discussed a recent analysis by the State Science and Technology Institute (May 28th Digest) of a study conducted by Pricewatershouse’s MoneyTree Report that indicates venture capital companies are making more investments in later stage companies and fewer investments in [...]
Filed under: SBIR, venture capital | Tagged: biotech, capitol hill, MoneyTree, SBIR, SBIRGA, SSTI, venture capital | 2 Comments »
Posted on March 24, 2008 by cartier@bio
House Small Business Committee Holds Hearing on the Reauthorization of the Small Business Innovation Research Program
Witness List
March 13, 2008
Chairwoman Velazquez’s (NY-12) led a lively hearing on the SBIR program in helping small businesses support promising research. She emphasized the importance of reinstating eligibility of majority venture capital-backed companies and highlighted the remedy offered in the [...]
Filed under: Congress, SBIR | Tagged: BIO, Congress, SBIR, venture capital | Leave a Comment »
Posted on March 7, 2008 by cartier@bio
Getting financing can be difficult. This news article from the Worcester Telegram & Gazette demonstrates the importance of SBIR funding.
“Not all start-up companies have been able to tap into venture capital to fund their businesses. Mr. Prescott of Crescent Innovations has secured federal Small Business Innovation Research funding, grants and money from [...]
Filed under: Finding Cures, SBIR, venture capital | Tagged: angel investors, biotechnology, financing, SBIR, start-up, venture capital | Leave a Comment »
